Skip to content
Frontiers
Search

Frontiers in Hematology

409
Citations
0
Views
0
Downloads
Submit manuscript

Explore open-access research in hematology, covering blood disorders, therapies, immunology, and cellular processes.

Frontiers in Hematology is a multidisciplinary platform dedicated to the dissemination of highquality scientific articles in hematology, bringing together experts to inspire and promote cuttingedge research. Led by Fi...

About the journal

  • Submit your research

    Start your submission and get more impact for your research by publishing with us.

  • Author guidelines

    Ready to publish? Check our author guidelines for everything you need to know about submitting, from choosing a journal and section to preparing your manuscript.

  • Editor guidelines

    Reviewing a manuscript? See our editor guidelines for everything you need to know about the Frontiers peer review process.

  • Peer review

    Our rigorous and transparent peer review combines expert assessment with constructive dialogue to strengthen your manuscript.

  • Publishing fees

    Article processing charges apply to articles accepted for publication by our external editors after rigorous peer review.

Editors

View all

Angela Fleischman

University of California, Irvine

United States

Specialty Chief Editor

Immunobiology and Immunotherapy

John Strouboulis

King's College London

United Kingdom

Specialty Chief Editor

Red Cells, Iron and Erythropoiesis

Louis Pelus

Department of Medicine, School of Medicine, Indiana University Bloomington

United States

Specialty Chief Editor

Hematopoiesis and Stem Cells

Savita Rangarajan

University of Southampton

United Kingdom

Specialty Chief Editor

Gene Therapy, Cell Therapy and Hematology

Stefano Molica

Hull University Teaching Hospitals NHS Trust

United Kingdom

Specialty Chief Editor

Blood Cancer

Akshay Sharma

St. Jude Children's Research Hospital

United States

Associate Editor

Gene Therapy, Cell Therapy and Hematology

96 editors · 0 reviewers

Articles

View all (50)

Research topics

View all (11)

About the journal

Scope

Frontiers in Hematology is a multidisciplinary platform dedicated to the dissemination of high-quality scientific articles in hematology, bringing together experts to inspire and promote cutting-edge research. Led by Field Chief Editor Hans Hasselbalch (University of Copenhagen, Denmark), Frontiers in Hematology seeks to advance our knowledge of all the factors that determine the presence or absence of hematological diseases and disorders. Frontiers in Hematology welcomes contributions in the various domains of hematological research, from basic to clinical studies. Topics of interest include: blood cancer hematopoiesis and stem cells immunobiology and immunotherapy red cells, iron and erythropoiesis. Articles that advance the UN’s Sustainable Development Goals (SDGs), especially SDG 3: good health and wellbeing, are particularly welcome. Frontiers in Hematology aims to be at the forefront of disseminating and communicating scientific advancements and impactful discoveries in the field of hematology to researchers, academics, clinicians, and the public worldwide.

Aims

Frontiers in Hematology is a multidisciplinary platform dedicated to the dissemination of high-quality scientific articles in hematology, bringing together experts to inspire and promote cutting-edge research.

Led by Field Chief Editor Hans Hasselbalch (University of Copenhagen, Denmark), Frontiers in Hematology seeks to advance our knowledge of all the factors that determine the presence or absence of hematological diseases and disorders.

Frontiers in Hematology welcomes contributions in the various domains of hematological research, from basic to clinical studies. Topics of interest include:

blood cancer

hematopoiesis and stem cells

immunobiology and immunotherapy

red cells, iron and erythropoiesis.

Articles that advance the UN’s Sustainable Development Goals (SDGs), especially SDG 3: good health and wellbeing, are particularly welcome.

Frontiers in Hematology aims to be at the forefront of disseminating and communicating scientific advancements and impactful discoveries in the field of hematology to researchers, academics, clinicians, and the public worldwide.

Source: https://www.frontiersin.org/journals/hematology/about

ISSN
2813-3935
Editor-in-Chief
Hans Carl Hasselbalch (Department of Hematology, Zealand University Hospital, Roskilde, Denmark) — Field Chief Editor
Established
2026

Sections

  • Blood Cancer

    Official section page: https://www.frontiersin.org/journals/hematology/sections/blood-cancer

  • Gene Therapy, Cell Therapy and Hematology

    Official section page: https://www.frontiersin.org/journals/hematology/sections/gene-therapy-cell-therapy-and-hematology

  • Hematopoiesis and Stem Cells

    Official section page: https://www.frontiersin.org/journals/hematology/sections/hematopoiesis-and-stem-cells

  • Immunobiology and Immunotherapy

    Official section page: https://www.frontiersin.org/journals/hematology/sections/immunobiology-and-immunotherapy

  • Red Cells, Iron and Erythropoiesis

    Official section page: https://www.frontiersin.org/journals/hematology/sections/red-cells-iron-and-erythropoiesis

Article types accepted

  • Original Research
  • Systematic Review
  • Methods
  • Review
  • Mini Review
  • Policy and Practice Reviews
  • Hypothesis and Theory
  • Perspective
  • Clinical Trial
  • Case Report
  • Community Case Study
  • Classification
  • Data Report
  • Policy Brief
  • Brief Research Report
  • General Commentary
  • Opinion
  • Correction
  • Editorial
  • Technology and Code
  • Study Protocol
  • FAIR² Data

Fees and currencies

  • Article processing charges (official)
  • - Category A: CHF 2,195 — Original Research, Systematic Review, Methods, Review, Policy and Practice Reviews, Hypothesis and Theory, Clinical Trial, Classification, Technology and Code, Study Protocol
  • - Category B: CHF 1,750 — Mini Review, Perspective, Case Report, Community Case Study, Data Report, Policy Brief, Brief Research Report, General Commentary, Opinion
  • - Category C: CHF 0 — Correction, Editorial
  • Currency: CHF

Fees are charged only after acceptance. Waivers and discounts are available for authors with limited funding.

Fees and waivers policy

Editorial policies

Peer review

  • Official peer-review process: https://www.frontiersin.org/about/peer-review

Publication ethics

  • Policies and publication ethics: https://www.frontiersin.org/guidelines/policies-and-publication-ethics

Indexing

  • Crossref
  • OpenAIRE
  • Scopus
  • Bielefeld Academic Search Engine (BASE)
  • CNKI Scholar
  • CLOCKSS
  • Dimensions
  • Chinese Academy of Sciences GoOA
  • EBSCO
  • Directory of Open Access Journals (DOAJ)
  • Committee on Publication Ethics (COPE)
  • Web of Science Emerging Sources Citation Index (ESCI)
  • ProQuest

Source: https://www.frontiersin.org/journals/hematology/about

Instructions for authors

Accepted article types

  • Original Research (fee category A)
  • Systematic Review (fee category A)
  • Methods (fee category A)
  • Review (fee category A)
  • Mini Review (fee category B)
  • Policy and Practice Reviews (fee category A)
  • Hypothesis and Theory (fee category A)
  • Perspective (fee category B)
  • Clinical Trial (fee category A)
  • Case Report (fee category B)
  • Community Case Study (fee category B)
  • Classification (fee category A)
  • Data Report (fee category B)
  • Policy Brief (fee category B)
  • Brief Research Report (fee category B)
  • General Commentary (fee category B)
  • Opinion (fee category B)
  • Correction (fee category C)
  • Editorial (fee category C)
  • Technology and Code (fee category A)
  • Study Protocol (fee category A)
  • FAIR² Data

Author guidelines

  • https://www.frontiersin.org/journals/hematology/for-authors/author-guidelines

Peer review

  • https://www.frontiersin.org/about/peer-review

Journal metrics

Citation score
1.2
Articles
50
Total views
0
Downloads
0
Citations
409

Internal metrics, calculated on this platform and maintained by the editorial office.

Official bibliometric indicators

Impact factor
1.2
CiteScore
1.2
Citations
409
Acceptance rate
33
Time to decision
35
Time to publication
98

Source: official publisher page · retrieved 2026-10-16

Some values were updated by the editorial office on 2026-10-23.